84 related articles for article (PubMed ID: 22104735)
21. Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection.
Molina MA; Carosi Diatricch L; Castany Quintana M; Melchers WJ; Andralojc KM
Expert Rev Mol Diagn; 2020 Nov; 20(11):1099-1120. PubMed ID: 33044104
[TBL] [Abstract][Full Text] [Related]
22. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
White CM; Bakhiet S; Bates M; Ruttle C; Pilkington LJ; Keegan H; O'Toole SA; Sharp L; O'Kelly R; Tewari P; Flannelly G; Martin CM; O'Leary JJ;
Cancer Epidemiol; 2020 Oct; 68():101793. PubMed ID: 32841926
[TBL] [Abstract][Full Text] [Related]
23. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening.
Wentzensen N; Lahrmann B; Clarke MA; Kinney W; Tokugawa D; Poitras N; Locke A; Bartels L; Krauthoff A; Walker J; Zuna R; Grewal KK; Goldhoff PE; Kingery JD; Castle PE; Schiffman M; Lorey TS; Grabe N
J Natl Cancer Inst; 2021 Jan; 113(1):72-79. PubMed ID: 32584382
[TBL] [Abstract][Full Text] [Related]
24. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
Mandal R; Ghosh I; Banerjee D; Mittal S; Muwonge R; Roy C; Panda C; Vernekar M; Frappart L; Basu P
Int J Gynecol Pathol; 2020 Jul; 39(4):384-390. PubMed ID: 32515923
[TBL] [Abstract][Full Text] [Related]
25. p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.
Han Q; Guo H; Geng L; Wang Y
Chin J Cancer Res; 2020 Apr; 32(2):208-217. PubMed ID: 32410798
[TBL] [Abstract][Full Text] [Related]
26. Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.
Benevolo M; Mancuso P; Allia E; Gustinucci D; Bulletti S; Cesarini E; Carozzi FM; Confortini M; Bisanzi S; Carlinfante G; Rubino T; Rollo F; Marchi N; Farruggio A; Pusiol T; Venturelli F; Giorgi Rossi P;
Cancer Cytopathol; 2020 May; 128(5):323-332. PubMed ID: 32168431
[TBL] [Abstract][Full Text] [Related]
27. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China.
Zhang SK; Jia MM; Zhao DM; Wu ZN; Guo Z; Liu YL; Guo PP; Chen Q; Cao XQ; Liu SZ; Chen W; Sun XB
Cancer Epidemiol; 2019 Apr; 59():123-128. PubMed ID: 30739069
[TBL] [Abstract][Full Text] [Related]
29. The distribution of novel biomarkers in carcinoma-in-situ, microinvasive, and squamous cell carcinoma of the uterine cervix.
Nicol AF; de Andrade CV; Gomes SC; Brusadelli MG; Lodin HM; Wells SI; Nuovo GJ
Ann Diagn Pathol; 2019 Feb; 38():115-122. PubMed ID: 30579259
[TBL] [Abstract][Full Text] [Related]
30. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis on the performance of p16/Ki-67 dual immunostaining in detecting high-grade cervical intraepithelial neoplasm.
Sun M; Shen Y; Ren ML; Dong YM
J Cancer Res Ther; 2018 Sep; 14(Supplement):S587-S593. PubMed ID: 30249873
[TBL] [Abstract][Full Text] [Related]
33. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
[TBL] [Abstract][Full Text] [Related]
34. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the association between the frequency of micronucleus and p
Gashi G; Mahovlić V; Bahtiri E; Kurshumliu F; Podrimaj-Bytyqi A; Elezaj IR
Biotech Histochem; 2018; 93(7):496-504. PubMed ID: 29790789
[TBL] [Abstract][Full Text] [Related]
36. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
37. [Value of p16/Ki-67 dual-staining immunocytochemistry in cervical cancer screening].
Xu SX; Lin JS; Zhan YM
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):207-208. PubMed ID: 29534364
[No Abstract] [Full Text] [Related]
38. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
39. [Clinical value of p16/Ki-67 immunocytochemical dual staining in cervical cancer screening].
Wang HR; Liao GD; Chen W; Qiao YL; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):636-640. PubMed ID: 28835090
[No Abstract] [Full Text] [Related]
40. Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review.
Silva DC; Gonçalves AK; Cobucci RN; Mendonça RC; Lima PH; Cavalcanti G
Pathol Res Pract; 2017 Jul; 213(7):723-729. PubMed ID: 28554769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
